Bleakley Financial Group, LLC Terns Pharmaceuticals, Inc. Transaction History

Bleakley Financial Group, LLC

  • $3.94 Trillion
  • Q2 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025
BUY
$5.53 - $8.36 $193,461 - $292,466
34,984 Added 262.8%
48,296 $268 Million
Q3 2024

Oct 16, 2024
BUY
$6.49 - $10.8 $17,853 - $29,710
2,751 Added 26.05%
13,312 $111 Million
Q2 2024

Aug 12, 2024
BUY
$4.54 - $8.2 $47,946 - $86,600
10,561 New
10,561 $71.9 Million
Q4 2023

Jan 25, 2024
BUY
$3.37 - $6.86 $35,223 - $71,700
10,452 New
10,452 $67.8 Million

Others Institutions Holding TERN

# of Institutions
142
Shares Held
84.3M
Call Options Held
256K
Put Options Held
133K
View Full List

About Terns Pharmaceuticals, Inc.

TERN Quotes by TradingView
  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $246M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email